Skip to main content
ES
v1.2
Log in
G

Gland Pharma

GLAND PHARMANSE
₹3,091+0.00 (+0.00%)
Market Cap
₹50,311Cr.
P/E Ratio
43.9
P/B Ratio
4.91
EPS (TTM)
₹70.41
Div Yield
0.65%
ROCE
15.1%
ROE
10.7%
52W Low: ₹1,57452W High: ₹3,171

At a glance

  • Sales have grown 21.0% a year over three years.
  • Debt is 0.03× its shareholders’ equity.

From reported financials and exchange prices. Descriptive only, not advice.

Gland_Pharma — Price
Interval
||
Style
Failed: 503

Scorecard

Market: risk-off · breadth 37
8/8Minerviniuptrend checks met
90RS Rankvs all stocks, 1–99
bullRSI Regimemomentum range
31 ▲Trend (ADX)trend strength
2/4CAN SLIMprice & volume checks
upSupertrendprice vs trailing line
accum.Volume Flowbuying vs selling volume

Factual technical classifications from price/volume data — research signals, not investment advice. Hover or tap any badge for what it means.

Evenstocks Score

Middle third
5.8/ 10Overall
3/ 10Valuation
6/ 10Quality
5/ 10Fundamental
9/ 10Growth

Investment Checklist

Quick assessment based on key parameters
Performance
N/ATrailing return unavailable
Valuation
P/E 43.9P/E: 43.9 | P/B: 4.91
Growth
GrowingSales CAGR — 3Y: 21% · 1Y: 18%
Profitability
ModerateROCE: 15.1% | ROE: 10.7%

Key Metrics

Valuation
PEG Ratio 5.49
Price / Sales 7.48x
Price / FCF 93.5x
Book Value ₹629
Margins & returns
Operating Margin 26%
Net Margin 16.8%
Return on Assets 9.1%

Frequently Asked Questions

MarketsPortfolioChart